CACACE ANGELA M (Chief Scientific Officer) sold 2.4% of their position (3.61K shares) of ARVINAS, INC. on the open market
Open‑market sale worth $43.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/25/2026ACC: 0001628280-26-011786
Officer· Chief Scientific Officer
Since Feb 2026
-3.61K
Net shares
Net seller
$43.9K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
3.61K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−1.04K
Price / share
$12.16
Trade value
$12.62K
% of position
0.7%
2/23/2026
151.23K→150.19K
Common Stock
Direct
Shares
−2.57K
Price / share
$12.16
Trade value
$31.26K
% of position
1.7%
2/23/2026
150.19K→147.62K
Total
Net shares
−3.61K
Net value
-$43.89K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/23/2026 | S · Sale | −1.04K | $12.16 | $12.62K | 0.7% | 151.23K | 150.19K |
| Common Stock Direct | 2/23/2026 | S · Sale | −2.57K | $12.16 | $31.26K | 1.7% | 150.19K | 147.62K |
| Total | −3.61K | -$43.89K | ||||||
Derivative Transactions0
No derivative transactions reported